Indian pharma stocks dropped sharply on September 26 after US President Donald Trump announced 100% tariffs on imported branded and patented medicines starting October 1. The move pressures companies to set up US-based production to avoid penalties.

BulletsIn

• Nifty Pharma index fell 2.54% in early trade
• Sun Pharma down 5%, hit yearly low at ₹1,547
• Biocon fell 3.3% to ₹344, Zydus down 2.8% to ₹990
• Aurobindo Pharma slid 2.4% to ₹1,070
• Dr. Reddy’s down 2.3% to ₹1,245.30
• Lupin and Cipla down 2% each; Torrent Pharma least hit at 1.5%
• Trump: 100% tariffs on branded, patent-protected medicines from Oct 1
• Exemption only if firms build or expand US manufacturing sites
• Policy aims to boost domestic drug production, cut import reliance
• Indian pharma majors face risk; domestic US producers may benefit